Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-02-02T02:43:44.108Z Has data issue: false hasContentIssue false

Assessing equity in preventing central line-associated bloodstream infections and surgical site infections in pediatric patients

Published online by Cambridge University Press:  27 January 2025

Xiaoyan Song*
Affiliation:
Office of Infection Control/Epidemiology, Children’s National Hospital, Washington, DC, USA The George Washington University, Washington, DC, USA
Deena Levey
Affiliation:
Office of Infection Control/Epidemiology, Children’s National Hospital, Washington, DC, USA
Jenhao Jacob Cheng
Affiliation:
Department of Quality & Patient Safety, Children’s National Hospital, Washington, DC, USA
Monica Monteon
Affiliation:
Office of Infection Control/Epidemiology, Children’s National Hospital, Washington, DC, USA
Annette Lee
Affiliation:
Office of Infection Control/Epidemiology, Children’s National Hospital, Washington, DC, USA
Nada Harik
Affiliation:
The George Washington University, Washington, DC, USA
Denice Cora-Bramble
Affiliation:
The George Washington University, Washington, DC, USA
Rahul K. Shah
Affiliation:
American Academy of Otolaryngology-Head & Neck Surgery, Alexandria, VA, USA
*
Corresponding author: Xiaoyan Song; Email: [email protected]

Abstract

Background:

Central line-associated bloodstream infections (CLABSIs) and surgical site infections (SSIs) are major healthcare-associated infections that can be prevented by consistently applying evidence-based infection prevention practices.

Objective:

To assess equity in preventing CLABSIs and SSIs in pediatric patients at a free-standing pediatric hospital, where evidence-based infection prevention practices are consistently implemented.

Methods:

This observational study evaluated 2 cohorts of pediatric patients under 18 years. The CLABSI cohort included inpatients with a central line between 1/1/2016 and 12/31/2022, and the SSI cohort included patients undergoing colon, ventricular shunt, or spinal fusion surgeries between 1/1/2016 and 10/31/2022. The CLABSI rate per 1000 central line days and SSI rate per 100 surgeries were compared across different racial, ethnic, and gender groups.

Results:

In the CLABSI cohort of 8575 patients, encompassing 243,803 central line days, there were 156 CLABSIs. There was no statistical difference in CLABSI rate across race, ethnicity, and/or gender groups. The SSI cohort included 68 SSIs among 1710 patients who underwent 2230 procedures, including 714 colon, 749 ventricular shunt, and 767 spinal fusion procedures. The SSI rate was statistically higher in multiracial (9.9) and Asian (8.6) groups, compared to Caucasian (2.4) and Black (2.2) groups. A nested case-control study of the SSI cohort showed a higher SSI rate in Asians, compared to Caucasians (Odds Ratio: 3.3; 95% CI: 1.3–8.3).

Conclusions:

Equity in preventing CLABSIs is achievable through standardized central-line care. Further study is warranted to assess if improvement opportunities exist for achieving equity in preventing SSIs.

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Introduction

Modern healthcare in the United States continues to strive for high-quality and safe patient care for the best patient outcomes. However, emerging evidence suggests disparities in patient outcomes based on demographics such as race, gender, ethnicity, and language proficiency. Reference Parikh, Hall and Tieder1 Central line-associated bloodstream infections (CLABSIs) and surgical site infections (SSIs) are broadly recognized as key indicators of healthcare quality and safety. 2,Reference Braun, Chitavi, Suzuki, Soyemi and Puig-Asensio3 Both outcomes have been utilized to evaluate and identify gaps in the provision of equitable and inclusive care and the few studies published to date resulted in variable findings. A single-center retrospective cohort study found elevated CLABSI rates among pediatric patients self-identifying as Black and those using a non-English language for medical care. These disparities persisted after adjusting for relevant risk factors. Reference McGrath, Bettinger and Stimpson4 A large cross-sectional study of adult patients undergoing colectomy or abdominal hysterectomy showed Black race was not associated with SSI in the colorectal or the hysterectomy groups. Reference Qi, Peacock, Luke, Barker, Olsen and Joynt Maddox5 However, a study utilizing the American College of Surgeons National Surgical Quality Improvement Program database revealed disparities in SSI rates between White/Non-Hispanic and Black/African-American patients across surgical subspecialties, Reference Welter, Grosh and Jose6 and another study using the same database showed an association with increased morbidity, mortality, and readmissions for Black patients across surgical procedures and specialties within 30-day post-surgery. Reference Azin, Hirpara, Doshi, Chesney, Quereshy and Chadi7

Amid these disparate findings, there has been a lack of pediatric-specific studies assessing equity in care as related to SSI risk. Moreover, strategies to prevent CLABSI and SSI are distinctly different. Specifically, CLABSIs that are defined by the Centers for Disease Control and Prevention to measure healthcare quality and safety occur primarily during a patient’s hospitalization in a healthcare setting. Therefore, stringent training and adherence to evidence-based best practices among healthcare providers are crucial and inevitable steps to prevent CLABSIs. On the other hand, SSIs can occur within 90 days after surgery, including after a patient has been discharged and is at home. Therefore, in addition to excellent hospital care by healthcare providers, preventing SSIs may demand a stronger partnership with patients and their caregivers at home to prevent these infections. This is particularly true for pediatric patients, whose care relies greatly on parents and guardians.

Taking together, we designed this study to assess if a patient’s sociodemographic factors including race, gender, ethnicity, and preferred language affect CLABSI and SSI rates in pediatric patients. By comparing CLABSI and SSI with their respective relationship with patients’ sociodemographic factors, we aimed to understand whether these factors were associated with varying infection risk, in the context of increased caregiver participation in the care of a patient at home.

Method

Study Setting: With the approval of the Institutional Review Board, the study was conducted at Children’s National Hospital (CNH), a free-standing pediatric facility located in Washington, D.C. serving patients in the greater metropolitan area. CNH has 323 beds for inpatient services that include level IV neonatal intensive care, pediatric intensive care, cardiovascular surgery intensive care, oncology, bone marrow and solid organ transplant, general pediatrics, and more. CNH also has 2 emergency departments and several outpatient primary and specialty clinics that serve pediatric children in Washington, D.C., and surrounding communities.

The Greater Washington region is home to 400 international associations and 1,000 internationally owned companies. 8 In 2014, some 90,000 D.C. residents, or 15 percent of the population spoke more than a dozen different languages. 8 During the study period, patients seen at CNH were 51% Black, 13% Caucasian, and 36% other races. Additionally, 69% of patients were not of Hispanic, Latino, or Spanish origin, 80% preferred English, and 19% preferred Spanish.

Study Design and Patient Population: The primary study design was a retrospective observational study including two cohorts of patients: the CLABSI cohort and the SSI cohort. The secondary study design was a nested case-control study using a subset of patients in the SSI cohort.

Patients in the CLABSI Cohort were selected from a line listing maintained by the Office of Infection Control for CLABSI surveillance and included patients who had a central line documented between January 1st, 2016 and December 31st, 2022 during an inpatient stay. Following CNH standard practice, nursing staff examined the central line including dressing status at the first encounter and hourly thereafter, and documented findings in the patient’s electronic medical record. Monthly, a computer program generated a list of patients with at least one documentation of a central line assessment. Infection Preventionists performed data validation using criteria established by the National Healthcare Safety Network (NHSN) and maintained the line listing for CLABSI surveillance. The Office of Infection Control also maintained a line listing of CLABSI cases that were identified by trained Infection Preventionists using NHSN definitions.

Patients in the SSI Cohort were selected from the SSI surveillance line listing maintained by the Office of Infection Control. Monthly, the Health Analytics team used Current Procedural Terminology codes defined by the NHSN to generate a list of patients undergoing ventricular shunt surgery, spinal fusion surgery, or colon surgery. Infection Preventionists then reviewed cases on the list to validate the procedure and identify SSIs using NHSN SSI definitions. The study included patients from the SSI surveillance line listing who had the surgery conducted between January 1st, 2016 and December 31st, 2022.

CNH electronic patient registry database was used to obtain demographic information including date of birth, self-reported gender, race, and ethnicity for patients in both the CLABSI cohort and the SSI cohort. Chart reviews were conducted for a nested case-control cohort that included SSI cases and randomly selected non-SSI cases (controls) to gather additional data including preferred language, interpreter use, and known SSI risk factors including age, wound classification, and American Society of Anesthesiologists (ASA) score. The cases and controls were matched only by surgery types.

Data Analysis: The analysis of the CLABSI cohort began with calculating the overall incidence rate (IR) per 1000 central-line days by dividing the number of CLABSIs by the number of central-line days. We then calculated the stratified IR by gender, race, and ethnicity. We employed Poisson regression to examine the statistical significance of variation in stratified incidence rates (IR). The 95% confidence interval (CI) was calculated to determine the statistical significance of differences in comparison groups.

The SSI cohort was analyzed by calculating the overall SSI rate per 100 procedures, obtained by dividing the number of SSIs by the total number of surgical procedures. Furthermore, we stratified the SSI rate by surgery type, gender, race, and ethnicity and examined the statistical significance of variation in these stratified rates using the chi-square test.

Mixed conditional logistic models were used to analyze the nested case-control data with the matching strata (surgery types) handled by a fixed effect and repeated patients by a random effect. One model was evaluated at a time for each of the patient demographics or risk factors using R software v4.3.1 (R Statistical Computing; Vienna, Austria) and mclogit package (v0.9.6; Elff 2022). Statistical significance was defined as P< 0.05 for two-sided tests.

Results

The CLABSI cohort included 8575 patients with a total of 243,803 central line days. During these central line days, 156 CLABSI episodes were identified in 134 patients, resulting in an overall CLABSI rate of 0.6 per 1000 central line days. The CLABSI rate in male and female groups was 0.7 and 0.6 per 1000 central line days, respectively (Incidence Rate Ratio [IRR]: 0.9; 95% CI: 0.6 – 1.2). Compared to the CLABSI rate of 0.6 per 1000 central line days in the Caucasian group, CLABSI rates in all other groups, including Black (IR: 0.6 per 1000 central line days; IRR: 1.1; 95% CI: 0.7–1.7), Native Hawaiian, Pacific Islander, or Other (IR: 0.7; IRR: 1.3; 95% CI: 0.8–2.0), Asian, multiracial, or information unavailable (IR: 0.8; IRR: 1.5; 95% CI: 0.7 – 3.1) were comparable with no significant difference detected (Table 1). The CLABSI rate in Not Hispanic, Latino, or Spanish Origin group was 0.6 per 1000 central line days, which was lower than the Hispanic, Latino, or Spanish Origin group (0.8 per 1000 central line days). However, the difference in rates between the two groups was not statistically significant (IRR: 1.2; 95% CI: 0.9 to 1.8). (Table 1).

Table 1. Result of unadjusted analysis between central line-associated bloodstream infections (CLABSIs) and patient’s race, ethnicity, and gender

* IRR: incidence rate ratio;

^ 95% CI: 95% confidence interval

The SSI cohort included 1710 patients who underwent 2230 procedures, including 714 colon, 749 ventricular shunt, and 767 spinal fusion procedures. Of these procedures, 68 SSIs were identified including 50 SSIs in colon surgeries, 7 SSIs in ventricular shunt surgeries, and 11 SSIs in spinal fusion surgeries. The overall SSI rate in the male and female groups were 3.8 and 2.5 per 100 procedures, respectively (IRR: 0.7; 95%: 0.4 – 1.1). The SSI rate was lowest in the Black (2.3 per 100 procedures), followed by Caucasians (2.5 per 100 procedures) and Other racial groups (3.2 per 100 procedures). (Table 2). The differences in the rates were not statistically significant. Asian, multiracial, or information unavailable groups had fewer than 100 procedures performed during the study period, resulting in high SSI rates ranging from 9.4 to 11.0 per 100 procedures in in Asian group and multiracial group, respectively. Both were statistically significantly higher than the Caucasian group. (Table 2).

Table 2. Unadjusted analysis between surgical site infections (SSIs) and patient’s race, ethnicity, and gender

* IRR: incidence rate ratio;

^ 95% CI: 95% confidence interval

The nested case-control cohort included 68 SSI cases and 272 randomly selected non-SSI cases that were matched by surgery type only. There was no statistically significant difference in the odds for SSI related to age, gender, ethnicity, preferred language (Spanish vs. English), use of interpreters, refusal of use of interpreters in the non-English speaking group, ASA score, and wound class (Table 3). Compared to the Caucasian group, the odds for SSI were significantly higher in the Asian group (Odds Ratio: 3.3, 95% CI: 1.3 – 8.3) (Table 3).

Table 3. Results of nested case-control study assessing surgical site infections (SSIs) and patient’s race, ethnicity, and gender

* OR: odds ratio;

^ 95% CI: 95% confidence interval

Discussions

This is the largest pediatric-specific study to date that has used hospital-based Healthcare Associated Infection (HAI) surveillance data to evaluate equity in care in relation to the quality and safety of patient care as measured by CLABSIs and SSIs. As previously reported, hospital-based data can accurately identify HAIs such as CLABSIs, but administrative data cannot. Reference Patrick, Davis and Sedman9 Therefore, unlike a previous study that demonstrates higher CLABSI rates among Black and Hispanic children than their White peers using an administrative database, Reference Willer, Tobias, Suttle, Nafiu and Mpody10 we find no disparity in CLABSI rates among pediatric patients of different genders, races, and ethnicities. Our achievement of equity in care is likely attributable to our institution-wide high-reliability central line care bundles and practices. In 2006, we implemented two central line care bundles (insertion and maintenance bundles) and two additional interventions (chlorhexidine scrub and chlorhexidine-impregnated sponges). Reference Niedner, Huskins and Colantuoni11,Reference Miller, Niedner and Huskins12 In 2011, we added chlorhexidine daily bathing in the pediatric intensive care unit (ICU) and cardiovascular surgery ICU. Reference Milstone, Elward and Song13 In 2014, we standardized central line care by integrating unit-specific protocols into one institutional nursing practice guideline. In 2015, we incorporated the CLABSI prevention bundles introduced by the Solutions for Patient Safety network. Reference Lyren, Brilli, Zieker, Marino, Muething and Sharek14 In addition to the progressive introduction of evidence-based practices, we recognize the significance of implementation science in maintaining high reliability in central line care, not only among nursing staff but also among providers, such as residents and anesthesiologists who may need to access a central line. Our implementation bundle integrates ongoing competency-based education, the development of training videos, the provision of central line dressing change kits with step-by-step guides and necessary products, systematic auditing for compliance, and the provision of just-in-time training and review. We encourage patients’ family members and caregivers to participate in the patient’s care; however, they must undergo training before and be supervised when handling a patient’s central line. These standard central line care bundles have not only reduced the risks of CLABSIs but also ensured equity of care in patients with a central line. Consequently, the CLABSI rate that our institution achieved during the study period was 39% lower than the pooled incident rate reported by 110 children’s hospitals that submitted CLABSI data to NHSN during the same period. Reference Prestel, Fike and Patel15

Of note, this is the first study to our knowledge that has included two types of HAIs in evaluating the relationship between HAI and demographic factors such as gender, race, and ethnicity. Similar to CLABSI prevention, we commit to providing standardized, evidence-based care to all patients undergoing surgery to ensure the best outcomes. Since 2016, we have implemented the SSI prevention bundle as recommended by Solutions for Patient Safety Network. Reference Lyren, Brilli, Zieker, Marino, Muething and Sharek14 We have achieved and maintained relatively low SSI rates in all three major procedures, colon, ventricular shunt, and spinal fusion, compared to the national pooled average of SSI rates across 287 pediatric hospitals. Reference Mathew, Salinas, Hsu, Jin, Rhee and Lee16 In addition, our SSI rates are uniformly low among Caucasian and Black groups and groups with different ethnicities, genders, preferred languages, and preferences for using interpreters. Our findings are different from previous studies showing higher SSI rates in Black groups. Reference Kawakita and Umans17,Reference Nafiu, Mpody, Kim, Uffman and Tobias18

Combining both CLABSI and SSI cohorts, the only disparity that our study found is a higher SSI rate among the Asian group. The observed disparities may be due to the small sample size of Asian patients in our SSI cohort. It may also be due to that the Asian group recorded in the patient’s medical record is a diverse group composed of different subgroups as no more specific data was obtained about cultural identity. However, previous studies have shown that the Asian group is associated with higher SSI rates and higher refusal rates for oncological treatment. Reference Pollack, Lowder, Keller, Chang, Gehlert and Olsen19Reference Lau, Tominez, Shing, Vo, Pollom and Taparra21 These findings highlight the need for targeted interventions in these minority groups for optimal patient outcomes.

We recognize that the study has two major weaknesses. One is that the retrospective nature of this cohort study using a hospital registry database as the data source for the demographic data is prone to known limitations. Reference Talari and Goyal22,Reference Sedgwick23 The other is that the study was conducted in one single center, therefore findings from this study may not be generalizable to all pediatric patient populations. Furthermore, our institution has aspired for high quality and safe care since 2009 when we began the Safety Transformation Initiative. Reference Hilliard, Sczudlo, Scafidi, Cady, Villard and Shah24Reference Hilliard26 In the “Journey to Zero,” the persistent adoption and enforcement of evidence-based standard care bundles and guidelines has empowered frontline healthcare providers to consistently deliver high-quality and safe care, effectively reducing disparities in patient outcomes to virtually zero. A major strength of this study lies in its considerable sample size. Furthermore, both cohorts of patients were sourced from the institution’s routine surveillance database, which is meticulously constructed and maintained to meet federal and local government requirements and comply with national standard definitions.

In conclusion, as evidenced by homogenous CLABSI rates across different racial, gender, and ethnical groups enrolled in this study, adherence to standard care practices is a powerful tool to prevent disparities in CLABSI risks. Further studies are warranted to identify strategies beyond standard care practices to achieve equity in preventing post-operative SSIs.

Acknowledgments

Contributors:

Dr. Xiaoyan Song conceptualized and designed the study drafted the initial manuscript, and critically reviewed and revised the manuscript.

Drs. Rahul Shah and Denice Cora-Bramble conceptualized the study, and critically reviewed and revised the manuscript.

Dr. Jenhao Jacob Cheng made a substantial contribution to the statistical analysis and data interpretation, drafted the initial manuscript, and critically reviewed and revised the manuscript.

Deena Levey, Monica Monteon, Annette Lee, and Nada Harik made a substantial contribution to the statistical analysis and data interpretation, and critically reviewed and revised the manuscript.

Financial support

None.

Competing interests

All authors have no conflicts of interest to disclose.

References

Parikh, K, Hall, M, Tieder, JS, et al. Disparities in racial, ethnic, and payer groups for pediatric safety events in US hospitals. Pediatrics 2024;153:e2023063714. doi: 10.1542/peds.2023-063714 CrossRefGoogle ScholarPubMed
Commission TJ. Central Line-Associated Bloodstream Infections Toolkit and Monograph. The Joint Commission 07/23/2024, 2024. Accessed 07/23/2024, 2024. https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/central-line-associated-bloodstream-infections-toolkit-and-monograph/#99bfb588eba64a349b3371d8eada0d1a Google Scholar
Braun, BI, Chitavi, SO, Suzuki, H, Soyemi, CA, Puig-Asensio, M. Culture of safety: impact on improvement in infection prevention process and outcomes. Curr Infect Dis Rep 2020;22:34. doi: 10.1007/s11908-020-00741-y CrossRefGoogle ScholarPubMed
McGrath, CL, Bettinger, B, Stimpson, M, et al. Identifying and mitigating disparities in central line-associated bloodstream infections in minoritized racial, ethnic, and language groups. JAMA Pediatr 2023;177:700709. doi: 10.1001/jamapediatrics.2023.1379 CrossRefGoogle ScholarPubMed
Qi, AC, Peacock, K, Luke, AA, Barker, A, Olsen, MA, Joynt Maddox, KE. Associations between social risk factors and surgical site infections after colectomy and abdominal hysterectomy. JAMA Netw Open 2019;2:e1912339. doi: 10.1001/jamanetworkopen.2019.12339 CrossRefGoogle ScholarPubMed
Welter, M, Grosh, K, Jose, J, et al. Are there racial differences in the rate of surgical site infection based on surgical subspecialty? Surg Infect (Larchmt) 2023;24:860868. doi: 10.1089/sur.2023.127 CrossRefGoogle ScholarPubMed
Azin, A, Hirpara, DH, Doshi, S, Chesney, TR, Quereshy, FA, Chadi, SA. Racial disparities in surgery: a cross-specialty matched comparison between black and white Patients. Ann Surg Open 2020;1:e023. doi: 10.1097/AS9.0000000000000023 CrossRefGoogle Scholar
DC Chamber of Commerce. WASHINGTON, DC: INTERNATIONAL BUSINESS GUIDE. Accessed February 17, 2024, 2024. https://dhs.dc.gov/sites/default/files/dc/sites/mayormb/publication/attachments/DC_InternationalBusinessGuide_online_high_res.pdf Google Scholar
Patrick, SW, Davis, MM, Sedman, AB, et al. Accuracy of hospital administrative data in reporting central line-associated bloodstream infections in newborns. Pediatrics 2013;131 : S75S80. doi: 10.1542/peds.2012-1427i CrossRefGoogle ScholarPubMed
Willer, BL, Tobias, JD, Suttle, ML, Nafiu, OO, Mpody, C. Trends of racial/ethnic disparities in pediatric central line-associated bloodstream infections. Pediatrics 2022;150:e2021054955. doi: 10.1542/peds.2021-054955 CrossRefGoogle ScholarPubMed
Niedner, MF, Huskins, WC, Colantuoni, E, et al. Epidemiology of central line-associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2011;32:12001208. doi: 10.1086/662621 CrossRefGoogle ScholarPubMed
Miller, MR, Niedner, MF, Huskins, WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 2011;128:e107783. doi: 10.1542/peds.2010-3675 CrossRefGoogle ScholarPubMed
Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013;381:10991106. doi: 10.1016/S0140-6736(12)61687-0 CrossRefGoogle ScholarPubMed
Lyren, A, Brilli, RJ, Zieker, K, Marino, M, Muething, S, Sharek, PJ. Children’s hospitals’ solutions for patient safety collaborative impact on hospital-acquired harm. Pediatrics 2017;140:e20163494. doi: 10.1542/peds.2016-3494 CrossRefGoogle ScholarPubMed
Prestel, C, Fike, L, Patel, P, et al. A review of pediatric central line-associated bloodstream infections reported to the national healthcare safety network: United States, 2016-2022. J Pediatric Infect Dis Soc 2023;12:519521. doi: 10.1093/jpids/piad066 CrossRefGoogle Scholar
Mathew, R, Salinas, JL, Hsu, HE, Jin, R, Rhee, C, Lee, GM. Pediatric surgical site infections in 287 hospitals in the United States, 2015-2018. Infect Control Hosp Epidemiol 2023;44:968970. doi: 10.1017/ice.2022.154 CrossRefGoogle Scholar
Kawakita, T, Umans, JG. Does a care bundle reduce racial disparities in postcesarean surgical site infections? Am J Perinatol 2019;36:13251331. doi: 10.1055/s-0039-1688822 Google ScholarPubMed
Nafiu, OO, Mpody, C, Kim, SS, Uffman, JC, Tobias, JD. Race, postoperative complications, and death in apparently healthy children. Pediatrics 2020;146:e20194113. doi: 10.1542/peds.2019-4113 CrossRefGoogle ScholarPubMed
Pollack, LM, Lowder, JL, Keller, M, Chang, SH, Gehlert, SJ, Olsen, MA. Racial/ethnic differences in the risk of surgical complications and posthysterectomy hospitalization among women undergoing hysterectomy for benign conditions. J Minim Invasive Gynecol 2021;28:10221032 e12. doi: 10.1016/j.jmig.2020.12.032 CrossRefGoogle ScholarPubMed
Huang, AE, Shih, JJ, Sunwoo, JB, Pollom, E, Taparra, K. Racial disparities in 30-day readmissions after surgery for head and neck cancer. Laryngoscope 2024;134:12821287. doi: 10.1002/lary.30997 CrossRefGoogle ScholarPubMed
Lau, B, Tominez, P, Shing, JZ, Vo, JB, Pollom, E, Taparra, K. Racial disparities among asian american, native hawaiian, and other pacific islander patients with cancer who refuse recommended radiation therapy or surgery. Cancers (Basel) 2023;15:3358. doi: 10.3390/cancers15133358 CrossRefGoogle ScholarPubMed
Talari, K, Goyal, M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb 2020;50:398402. doi: 10.4997/JRCPE.2020.409 CrossRefGoogle ScholarPubMed
Sedgwick, P. Retrospective cohort studies: advantages and disadvantages. BMJ 2014;348:g1072. doi: 10.1136/bmj.f7707 CrossRefGoogle Scholar
Hilliard, MA, Sczudlo, R, Scafidi, L, Cady, R, Villard, A, Shah, R. Our journey to zero: reducing serious safety events by over 70% through high-reliability techniques and workforce engagement. J Healthc Risk Manag 2012;32:418. doi: 10.1002/jhrm.21090 CrossRefGoogle ScholarPubMed
Hilliard, MA. Finding our way together on the journey to zero. J Healthc Risk Manag 2012;31:12. doi: 10.1002/jhrm.20098 Google ScholarPubMed
Hilliard, MA. Gaining momentum in the long, uphill battle to “get to zero”. J Healthc Risk Manag 2012;31:12. doi: 10.1002/jhrm.20097 Google Scholar
Figure 0

Table 1. Result of unadjusted analysis between central line-associated bloodstream infections (CLABSIs) and patient’s race, ethnicity, and gender

Figure 1

Table 2. Unadjusted analysis between surgical site infections (SSIs) and patient’s race, ethnicity, and gender

Figure 2

Table 3. Results of nested case-control study assessing surgical site infections (SSIs) and patient’s race, ethnicity, and gender